SELENA CLEARMAN: Open Payments
NPI 1518944560 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,193 in 72 payments from 15 companies in 2025. Trend: 2023 $1,209 · 2024 $1,090 · 2025 $1,193
Food & beverage: $1,193
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $278 |
| ABBVIE INC. | 22 | $263 |
| Novo Nordisk Inc | 17 | $202 |
| Exact Sciences Corporation | 4 | $97 |
| Lilly USA, LLC | 3 | $55 |
| Amgen Inc. | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Lundbeck LLC | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Abbott Laboratories | 2 | $33 |
Products named: FARXIGA, VRAYLAR, QULIPTA, AIRSUPRA, Ozempic, The Cologuard Plus Collection Kit, Rybelsus, MOUNJARO.
Industry payments across MS — which companies pay providers there.
